{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:54:08Z","timestamp":1789430048712,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Observational studies suggested a link between vitamin D deficiency (VDD) and diabetic retinopathy (DR). However, evidence from interventional studies on possible effects of VDD correction on retinal microvasculature in DR is scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This single-arm exploratory interventional study included 60 eyes from 30 patients with VDD and type 2 diabetes mellitus (DM), without DR or with mild or moderate non-proliferative DR (NPDR). Participants received oral vitamin D\n                      <jats:sub>3<\/jats:sub>\n                      (50,000 IU\/week for 8 weeks) followed by a daily maintenance dose (800 IU). Optical coherence tomography angiography (OCTA) imaging was performed before and three months after vitamin D repletion. Outcome measures were macular perfusion parameters and best-corrected visual acuity (BCVA). Linear mixed effects models were used to evaluate the association between changes in outcome measures with change in serum 25(OH)D\n                      <jats:sub>3<\/jats:sub>\n                      levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean serum 25(OH)D\n                      <jats:sub>3<\/jats:sub>\n                      level increased significantly post-intervention (14.20\u2009\u00b1\u20094.04 to 55.82\u2009\u00b1\u20096.79 ng\/mL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and VDD was corrected in all patients. A small improvement was noted in BCVA with marginal statistical significance (0.12\u2009\u00b1\u20090.13 to 0.10\u2009\u00b1\u20090.13 Logarithm of the Minimum Angle of Resolution;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.051). Other than a small reduction in parafoveal superficial vessel density at the superior quadrant (-3.23\u2009\u00b1\u20096.66%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011), none of the perfusion metrics had changed three months after VDD correction. Linear models yielded no association between changes in serum 25(OH)D\n                      <jats:sub>3<\/jats:sub>\n                      levels and alterations in BCVA or OCTA macular perfusion metrics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on this non-controlled interventional study, short-term effects of VDD correction in people with DM without severe DR does not appear to significantly influence the visual acuity or macular perfusion profile on OCTA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40942-026-00822-5","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T06:54:29Z","timestamp":1771916069000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vitamin D supplementation in diabetic retinopathy: an optical coherence tomography angiography study of changes in macular perfusion"],"prefix":"10.1186","volume":"12","author":[{"given":"Sahba","family":"Fekri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golnar","family":"Hassanzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosein","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sare","family":"Safi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooshin","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Khorrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed-Hossein","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"3","key":"822_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.2337\/dc16-2641","volume":"40","author":"SD Solomon","year":"2017","unstructured":"Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, et al. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care. 2017;40(3):412\u20138.","journal-title":"Diabetes Care"},{"issue":"4","key":"822_CR2","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","volume":"9","author":"MJ Burton","year":"2021","unstructured":"Burton MJ, Ramke J, Marques AP, Bourne RRA, Congdon N, Jones I, et al. The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. Lancet Glob Health. 2021;9(4):e489\u2013551.","journal-title":"Lancet Glob Health"},{"issue":"12","key":"822_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","volume":"18","author":"AM Joussen","year":"2004","unstructured":"Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18(12):1450\u20132.","journal-title":"FASEB J"},{"issue":"8","key":"822_CR4","doi-asserted-by":"publisher","first-page":"e3447","DOI":"10.1002\/dmrr.3447","volume":"37","author":"MS Valle","year":"2021","unstructured":"Valle MS, Russo C, Malaguarnera L. Protective role of vitamin D against oxidative stress in diabetic retinopathy. Diabetes Metab Res Rev. 2021;37(8):e3447.","journal-title":"Diabetes Metab Res Rev"},{"key":"822_CR5","doi-asserted-by":"crossref","unstructured":"Wang W, Lo ACY. Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci. 2018;19(6).","DOI":"10.3390\/ijms19061816"},{"issue":"6","key":"822_CR6","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.2337\/dc12-0790","volume":"36","author":"K Harris Nwanyanwu","year":"2013","unstructured":"Harris Nwanyanwu K, Talwar N, Gardner TW, Wrobel JS, Herman WH, Stein JD. Predicting Development of Proliferative Diabetic Retinopathy. Diabetes Care. 2013;36(6):1562\u20138.","journal-title":"Diabetes Care"},{"issue":"6","key":"822_CR7","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.survophthal.2024.07.001","volume":"69","author":"SH Sinclair","year":"2024","unstructured":"Sinclair SH, Schwartz S. Diabetic retinopathy: New concepts of screening, monitoring, and interventions. Surv Ophthalmol. 2024;69(6):882\u201392.","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"822_CR8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1097\/CM9.0000000000001364","volume":"134","author":"WJ Zhao","year":"2021","unstructured":"Zhao WJ, Xia XY, Yin J. Relationship of serum vitamin D levels with diabetic microvascular complications in patients with type 2 diabetes mellitus. Chin Med J (Engl). 2021;134(7):814\u201320.","journal-title":"Chin Med J (Engl)"},{"issue":"8","key":"822_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.4158\/EP-2019-0015","volume":"25","author":"H Wan","year":"2019","unstructured":"Wan H, Wang Y, Zhang K, Chen Y, Fang S, Zhang W, et al. Associations Between Vitamin D and Microvascular Complications in Middle-Aged And Elderly Diabetic Patients. Endocr Pract. 2019;25(8):809\u201316.","journal-title":"Endocr Pract"},{"issue":"4","key":"822_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s11154-020-09575-4","volume":"22","author":"F Tecilazich","year":"2021","unstructured":"Tecilazich F, Formenti AM, Giustina A. Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects. Rev Endocr Metab Disord. 2021;22(4):715\u201327.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"822_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12902-022-01084-6","volume":"22","author":"Z Maghbooli","year":"2022","unstructured":"Maghbooli Z, Ebrahimi Meimand S, Malek Hosseini AA, Shirvani A. Alterations in circulating levels of vitamin D binding protein, total and bioavailability of vitamin D in diabetic retinopathy patients. BMC Endocr Disord. 2022;22(1):169.","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"822_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.2337\/dc22-0513","volume":"46","author":"X Chen","year":"2023","unstructured":"Chen X, Wan Z, Geng T, Zhu K, Li R, Lu Q, et al. Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Microvascular Complications Among Individuals With Type 2 Diabetes: A Prospective Study. Diabetes Care. 2023;46(2):270\u20137.","journal-title":"Diabetes Care"},{"key":"822_CR13","doi-asserted-by":"crossref","unstructured":"Trott M, Driscoll R, Pardhan S. Associations between diabetic retinopathy and modifiable risk factors: an umbrella review of meta-analyses. Diabet Med. 2022;39(6).","DOI":"10.1111\/dme.14796"},{"issue":"5","key":"822_CR14","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.numecd.2024.01.033","volume":"34","author":"C Huang","year":"2024","unstructured":"Huang C, Luo D, Sun M, Fang G, Wei M, Zhang Y, et al. No causal association between serum vitamin D levels and diabetes retinopathy: A Mendelian randomization analysis. Nutr Metabolism Cardiovasc Dis. 2024;34(5):1295\u2013304.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"key":"822_CR15","doi-asserted-by":"publisher","first-page":"1431170","DOI":"10.3389\/fmed.2024.1431170","volume":"11","author":"S Fan","year":"2024","unstructured":"Fan S, Shi XY, Li X, Li J, Yu SP. Vitamin D levels and risk of ocular disorders: insights from bidirectional and multivariable Mendelian randomization analysis. Front Med (Lausanne). 2024;11:1431170.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"822_CR16","doi-asserted-by":"publisher","first-page":"8701","DOI":"10.1038\/s41598-025-93613-1","volume":"15","author":"X Luo","year":"2025","unstructured":"Luo X, Ruan Z, Liu L. Causal effect of the 25-Hydroxyvitamin D concentration on ocular diseases: A Mendelian randomization study. Sci Rep. 2025;15(1):8701.","journal-title":"Sci Rep"},{"issue":"11","key":"822_CR17","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1007\/s10792-022-02333-2","volume":"42","author":"S Fekri","year":"2022","unstructured":"Fekri S, Soheilian M, Roozdar S, Abtahi SH, Nouri H. The effect of vitamin D supplementation on the outcome of treatment with bevacizumab in diabetic macular edema: a randomized clinical trial. Int Ophthalmol. 2022;42(11):3345\u201356.","journal-title":"Int Ophthalmol"},{"key":"822_CR18","doi-asserted-by":"publisher","unstructured":"Karimi S, Movafaghi V, Arabi A, Shahraki T, Safi S. Effects of oral vitamin D supplement therapy on clinical outcomes of intravitreal bevacizumab in diabetic macular edema. J Ophthalmic Vis Res. 2021 Jan 20;16(1):34-41. https:\/\/doi.org\/10.18502\/jovr.v16i1.8249. PMID: 33520126; PMCID: PMC7841288.","DOI":"10.18502\/jovr.v16i1.8249"},{"issue":"1","key":"822_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/nu5010111","volume":"5","author":"M Wacker","year":"2013","unstructured":"Wacker M, Holick MF. Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5(1):111\u201348.","journal-title":"Nutrients"},{"issue":"1","key":"822_CR20","doi-asserted-by":"publisher","first-page":"e10432","DOI":"10.1002\/jbm4.10432","volume":"5","author":"MR Haussler","year":"2021","unstructured":"Haussler MR, Livingston S, Sabir ZL, Haussler CA, Jurutka PW. Vitamin D Receptor Mediates a Myriad of Biological Actions Dependent on Its 1,25-Dihydroxyvitamin D Ligand: Distinct Regulatory Themes Revealed by Induction of Klotho and Fibroblast Growth Factor-23. JBMR Plus. 2021;5(1):e10432.","journal-title":"JBMR Plus"},{"issue":"2","key":"822_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/ijd.13407","volume":"56","author":"Q Li","year":"2017","unstructured":"Li Q, Wu Y, Niu M, Lu X, Huang Y, He D. Protective effects of tacalcitol against oxidative damage in human epidermal melanocytes. Int J Dermatol. 2017;56(2):232\u20138.","journal-title":"Int J Dermatol"},{"issue":"1","key":"822_CR22","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bbrc.2014.07.081","volume":"451","author":"W Jang","year":"2014","unstructured":"Jang W, Kim HJ, Li H, Jo KD, Lee MK, Song SH, et al. 1,25-Dyhydroxyvitamin D3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy. Biochem Biophys Res Commun. 2014;451(1):142\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"822_CR23","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1167\/iovs.06-1210","volume":"48","author":"DM Albert","year":"2007","unstructured":"Albert DM, Scheef EA, Wang S, Mehraein F, Darjatmoko SR, Sorenson CM, et al. Calcitriol Is a Potent Inhibitor of Retinal Neovascularization. Invest Opthalmology Visual Sci. 2007;48(5):2327.","journal-title":"Invest Opthalmology Visual Sci"},{"key":"822_CR24","doi-asserted-by":"publisher","first-page":"101206","DOI":"10.1016\/j.preteyeres.2023.101206","volume":"97","author":"NK Waheed","year":"2023","unstructured":"Waheed NK, Rosen RB, Jia Y, Munk MR, Huang D, Fawzi A, et al. Optical coherence tomography angiography in diabetic retinopathy. Prog Retin Eye Res. 2023;97:101206.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"822_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.diabet.2011.01.001","volume":"37","author":"E Cavalier","year":"2011","unstructured":"Cavalier E, Delanaye P, Souberbielle JC, Radermecker RP. Vitamin D and type 2 diabetes mellitus: Where do we stand? Diabetes Metab. 2011;37(4):265\u201372.","journal-title":"Diabetes Metab"},{"issue":"9","key":"822_CR26","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","volume":"110","author":"CP Wilkinson","year":"2003","unstructured":"Wilkinson CP, Ferris FL, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677\u201382.","journal-title":"Ophthalmology"},{"issue":"1","key":"822_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/biomedicines13010068","volume":"13","author":"CE Petrea","year":"2024","unstructured":"Petrea CE, Ghenciu LA, Iacob R, Stoicescu ER, S\u0103ndesc D. Vitamin D Deficiency as a Risk Factor for Diabetic Retinopathy: A Systematic Review and Meta-Analysis. Biomedicines. 2024;13(1):68.","journal-title":"Biomedicines"},{"issue":"2","key":"822_CR28","first-page":"326","volume":"8","author":"S Bonakdaran","year":"2015","unstructured":"Bonakdaran S, Shoeibi N. Is there any correlation between vitamin D insufficiency and diabetic retinopathy? Int J Ophthalmol. 2015;8(2):326\u201331.","journal-title":"Int J Ophthalmol"},{"issue":"12","key":"822_CR29","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.3390\/nu13124302","volume":"13","author":"E Girard","year":"2021","unstructured":"Girard E, Nacher M, Bukasa-Kakamba J, Fahrasmane A, Adenis A, Massicard M, et al. Vitamin D Deficiency in Patients with Diabetes in French Guiana: Epidemiology and Relation with Microvascular and Macrovascular Complications. Nutrients. 2021;13(12):4302.","journal-title":"Nutrients"},{"key":"822_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6156217","volume":"2016","author":"U Alam","year":"2016","unstructured":"Alam U, Amjad Y, Chan AWS, Asghar O, Petropoulos IN, Malik RA. Vitamin D Deficiency Is Not Associated with Diabetic Retinopathy or Maculopathy. J Diabetes Res. 2016;2016:1\u20137.","journal-title":"J Diabetes Res"},{"issue":"2","key":"822_CR31","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.atherosclerosis.2013.03.024","volume":"228","author":"JD Alele","year":"2013","unstructured":"Alele JD, Luttrell LM, Hollis BW, Luttrell DK, Hunt KJ. Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial. Atherosclerosis. 2013;228(2):502\u20137.","journal-title":"Atherosclerosis"},{"issue":"1","key":"822_CR32","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s40200-022-01059-3","volume":"21","author":"M Trott","year":"2022","unstructured":"Trott M, Driscoll R, Iraldo E, Pardhan S. Associations between vitamin D status and sight threatening and non-sight threatening diabetic retinopathy: a systematic review and meta-analysis. J Diabetes Metab Disord. 2022;21(1):1177\u201384.","journal-title":"J Diabetes Metab Disord"},{"key":"822_CR33","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.jcjo.2017.09.026","volume":"52","author":"J Zhang","year":"2017","unstructured":"Zhang J, Upala S, Sanguankeo A. Relationship between vitamin D deficiency and diabetic retinopathy: a meta-analysis. Can J Ophthalmol. 2017;52:S39\u201344.","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"822_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0009-9120(99)00085-5","volume":"33","author":"H Aksoy","year":"2000","unstructured":"Aksoy H, Ak\u00e7ay F, Kurtul N, Baykal O, Avci B. Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem. 2000;33(1):47\u201351.","journal-title":"Clin Biochem"},{"key":"822_CR35","doi-asserted-by":"crossref","unstructured":"Chan HN, Zhang XJ, Ling XT, Bui CHT, Wang YM, Ip P, et al. Vitamin D and ocular diseases: a systematic review. Int J Mol Sci. 2022;23(8).","DOI":"10.3390\/ijms23084226"},{"issue":"1","key":"822_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12020-008-9115-5","volume":"35","author":"LG Danescu","year":"2009","unstructured":"Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine. 2009;35(1):11\u20137.","journal-title":"Endocrine"},{"issue":"7","key":"822_CR37","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00125-005-1802-7","volume":"48","author":"C Mathieu","year":"2005","unstructured":"Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia. 2005;48(7):1247\u201357.","journal-title":"Diabetologia"},{"issue":"4","key":"822_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s10456-005-9024-7","volume":"8","author":"S Kalkunte","year":"2006","unstructured":"Kalkunte S, Brard L, Granai CO, Swamy N. Inhibition of angiogenesis by vitamin D-binding protein: Characterization of anti-endothelial activity of DBP-maf. Angiogenesis. 2006;8(4):349\u201360.","journal-title":"Angiogenesis"},{"issue":"12","key":"822_CR39","doi-asserted-by":"publisher","first-page":"e0190131","DOI":"10.1371\/journal.pone.0190131","volume":"12","author":"N Jamali","year":"2017","unstructured":"Jamali N, Wang S, Darjatmoko SR, Sorenson CM, Sheibani N. Vitamin D receptor expression is essential during retinal vascular development and attenuation of neovascularization by 1, 25(OH)2D3. PLoS ONE. 2017;12(12):e0190131.","journal-title":"PLoS ONE"},{"issue":"3","key":"822_CR40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/aos.13384","volume":"96","author":"R Opatrilova","year":"2018","unstructured":"Opatrilova R, Kubatka P, Caprnda M, B\u00fcsselberg D, Krasnik V, Vesely P, et al. Nitric oxide in the pathophysiology of retinopathy: evidences from preclinical and clinical researches. Acta Ophthalmol. 2018;96(3):222\u201331.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"822_CR41","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4103\/1673-5374.355743","volume":"18","author":"L Tang","year":"2023","unstructured":"Tang L, Xu GT, Zhang JF. Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy. Neural Regen Res. 2023;18(5):976\u201382.","journal-title":"Neural Regen Res"},{"issue":"1","key":"822_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12933-016-0434-1","volume":"15","author":"AE Millen","year":"2016","unstructured":"Millen AE, Sahli MW, Nie J, LaMonte MJ, Lutsey PL, Klein BEK, et al. Adequate vitamin D status is associated with the reduced odds of prevalent diabetic retinopathy in African Americans and Caucasians. Cardiovasc Diabetol. 2016;15(1):128.","journal-title":"Cardiovasc Diabetol"},{"key":"822_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12933-015-0231-2","volume":"14","author":"L Engelen","year":"2015","unstructured":"Engelen L, Schalkwijk CG, Eussen SJPM, Scheijen JLJM, Soedamah-Muthu SS, Chaturvedi N, et al. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study. Cardiovasc Diabetol. 2015;14:67.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"822_CR44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2337\/dc14-0180","volume":"38","author":"M Herrmann","year":"2015","unstructured":"Herrmann M, Sullivan DR, Veillard AS, McCorquodale T, Straub IR, Scott R, et al. Serum 25-Hydroxyvitamin D: A Predictor of Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes. Diabetes Care. 2015;38(3):521\u20138.","journal-title":"Diabetes Care"},{"issue":"Supplement1","key":"822_CR45","first-page":"S111","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, Ekhlaspour L, et al. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes\u20142024. Diabetes Care. 2024;47(Supplement1):S111\u201325.","journal-title":"Diabetes Care"},{"issue":"11","key":"822_CR46","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1055\/a-1010-6449","volume":"51","author":"J Yuan","year":"2019","unstructured":"Yuan J, Zhou JB, Zhao W, Zhang RH, Cai YH, Shu LP, et al. Could Vitamin D be Associated with Proliferative Diabetic Retinopathy? Evidence from Pooling Studies. Horm Metab Res. 2019;51(11):729\u201334.","journal-title":"Horm Metab Res"},{"issue":"3","key":"822_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/nu9030307","volume":"9","author":"BA Luo","year":"2017","unstructured":"Luo BA, Gao F, Qin LL. The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis of Observational Studies. Nutrients. 2017;9(3):307.","journal-title":"Nutrients"},{"issue":"3","key":"822_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1167\/iovs.63.3.25","volume":"63","author":"B Lal","year":"2022","unstructured":"Lal B, Alonso-Caneiro D, Read SA, Tran B, Van Bui C, Tang D, et al. Changes in Retinal Optical Coherence Tomography Angiography Indexes Over 24 Hours. Invest Ophthalmol Vis Sci. 2022;63(3):25.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-026-00822-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-026-00822-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:45:22Z","timestamp":1781635522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40942-026-00822-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["822"],"URL":"https:\/\/doi.org\/10.1186\/s40942-026-00822-5","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involved human participants. The protocol was approved by the Ophthalmic Research Center Ethics Committee at Shahid Beheshti University of Medical Sciences (Ethics approval code: IR.SBMU.MSP.REC.1400.833). The study was conducted in accordance with the Declaration of Helsinki. Written informed consent to participate was obtained from all individual participants prior to enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}